Core Wealth Advisors’s SPDR S&P Biotech ETF XBI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-26
| Closed | -$2.47K | – | 244 |
|
|
2024
Q1 | $2.47K | Sell |
26
-23
| -47% | -$2.18K | ﹤0.01% | 240 |
|
|
2023
Q4 | $4.38K | Hold |
49
| – | – | ﹤0.01% | 223 |
|
|
2023
Q3 | $3.58K | Hold |
49
| – | – | ﹤0.01% | 206 |
|
|
2023
Q2 | $4.08K | Sell |
49
-3
| -6% | -$250 | ﹤0.01% | 201 |
|
|
2023
Q1 | $3.96K | Sell |
52
-1,328
| -96% | -$101K | ﹤0.01% | 206 |
|
|
2022
Q4 | $115K | Sell |
1,380
-95
| -6% | -$7.89K | 0.05% | 56 |
|
|
2022
Q3 | $117K | Sell |
1,475
-468
| -24% | -$37.1K | 0.07% | 45 |
|
|
2022
Q2 | $144K | Buy |
1,943
+1,383
| +247% | +$102K | 0.09% | 41 |
|
|
2022
Q1 | $50K | Buy |
+560
| New | +$50K | 0.03% | 80 |
|